Health Canada Approves Controversial HPV Vaccine For Males

(LifeSiteNews.com) — Vaccine manufacturer Merck Frosst Pharmaceutical announced yesterday that they have approval from Health Canada for the use of the human papilloma virus HPV vaccine Gardasil in boys and young men.

Gardasil was approved by Health Canada in 2006 for females between the ages of nine and 26, with the goal of preventing cervical cancer and genital warts. In males the same age group is targeted, with the intent of combating genital warts and anal cancer.

The U.S. government watchdog agency Judicial Watch, which has tracked the use of the vaccine since it was approved by the FDA, has repeatedly raised concerns over the safety of Gardasil and questions both the safety and usefulness of administering the vaccine to males.

via Health Canada Approves Controversial HPV Vaccine For Males.

Be the first to comment

Leave a Reply

Your email address will not be published.


*